BIRC2 and pachyonychia congenita: Collectively, these findings suggest that CITED4-mediated BIRC2 expression ultimately contributes to GEM resistance by regulating the drug resistance-related genes, thereby influencing anti-apoptosis and cell cycle pathways, ultimately promoting chemoresistance in PC.